← Back to news
S

Seeking Alpha: News

Costco GAAP EPS of $4.58 beats by $0.04, revenue of $69.6B beats by $280M

B

Myers Industries outlines 2026 transformation priorities and targets 3% CapEx of sales while emphasizing margin expansion

B

Earnings Snapshot: Marvell tops FQ4 consensus, issues healthy guidance

B

Full House Resorts GAAP EPS of -$0.34 misses by $0.10, revenue of $75.5M in-line

B

Tokenized securities face similar capital rules as non-tokenized forms - Bank regulators

B

NexGen Energy started with Buy rating at UBS, seeing Rook I as a tier-1 project

B

Algonquin Power & Utilities Q4 2025 Earnings Preview

B

CPI Card Group outlines new segment strategy and targets over 15% growth in Integrated Paytech amid digital push

B

NewLake Capital Partners Q4 2025 Earnings Preview

B

Methode Electronics Q3 2026 Earnings Preview

B

Imperial Petroleum Q4 Earnings Preview

B

Embraer Q4 2025 Earnings Preview

B

Most and least shorted consumer discretionary stocks with up to $2B market cap as of end-Feb

B

Seadrill raised from Sell rating at Citi on improved visibility into 2026-27

B

Vicor slides as chip stocks sell off on AI export concerns, geopolitical risks

B

BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures

B

Mistras Group targets $730M–$750M 2026 revenue with increased CapEx for aerospace and defense

B

Global Water Resources outlines $70M rate base expansion and signals focus on expense control for 2026

B

ImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share

B

PSEG and Southern raised, Duke Energy cut at Evercore ISI in utility ratings shuffle

B

CorMedix outlines $300M–$320M revenue and $100M–$125M EBITDA targets for 2026 amid DefenCath transition and Melinta integration

B

Oil tops $80/bbl and hits a 19-month high as Middle East tensions ignite an energy rally

B

Evaxion Biotech ADS GAAP EPS of -$0.02 beats by $0.01

B

Universal Music Group reports Q4 results

B

Dow loses more than 1,000 points on oil price surge, inflation fears reigniting

B

Trump removes Noem as Homeland Security head after congressional clashes

B

Volkswagen tests defense vehicle concepts as it weighs future of Osnabrück plant

B

Burlington protects margins, manages expenses to see another strong quarter

B

Don't expect February's nonfarm payrolls report to repeat January's upside surprise

B

J&J wins FDA nod for multiple myeloma therapy

B

Ranpak outlines 2026 revenue growth target of up to 12.7% while advancing automation and expanding major partnerships

B

Antero Resources upgraded, Diamondback and others downgraded at Benchmark

B

Intrepid projects 7% Trio production growth for 2026 while deferring AMAX decision

B

Rocket Cos., UWM Holdings slide after Better partners with OpenAI on mortgage decision app

B

Lightwave Logic GAAP EPS of -$0.04, revenue of $25.6M

B

El Pollo Loco makes menu innovation a big priority for 2026

B

Altimmune outlines 1,800-patient Phase III MASH trial and signals cash runway into 2028 as pemvidutide advances

B

Acorn Energy targets 20% annual revenue growth through AIO partnership and expanded monitoring solutions

B

Ciena outlines $5.9B–$6.3B revenue outlook for 2026 while expanding AI-driven optical market leadership

B

WISeKey ADS reports Q4 results

B

OpenAI CEO says government should be more powerful than companies

B

Canadian Natural rises after Q4 earnings beat; to defer Jackpine mine expansion

B

Spin Master Non-GAAP EPS of $0.41, revenue of $618.2M beats by $13.89M

B

Air Canada starts a new fleet era with Boeing 737 MAX 8 aircraft in service

B

PagSeguro Non-GAAP EPS of R$2.33, revenue of R$3.5B

B

Fed's pause in January will help it assess prior rate cuts' effects, Bowman says

B

Barkin says Fed's response to Iran war will depend on duration

B

Harbour Energy plc reports FY results

B

NACCO outlines significant capital investments for 2026 amid utility coal mining recovery and new infrastructure contracts

S

Aquestive plans 75-rep Anaphylm launch and targets $46M–$50M in 2026 revenue while doubling medical affairs

S